TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Clinical trial NCT05343013 · RECRUITING
Trial details
- NCT number
- NCT05343013
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2027-05-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.